Hepatic Steatosis Assessment as a New Strategy for the Metabolic and Nutritional Management of Duchenne Muscular Dystrophy

@Stmkrs @HealthcareNinj1 I think the rationale is pretty strong tbh. Non-Ambulatory patients usually have far higher rates of hepatic steatosis https://t.co/vutn231nuj

This study (Taiwan) investigated metabolic syndrome and hepatic steatosis (fatty liver, HS) in young people with #DMD. Using ultrasound, researchers identified 40% of the cohort had sig. HS. Important to consider in #nutrition ax Full text available he…